{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P40136",
      "entity_text" : "EF",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In a study of such patients treated with 25 mg trimetazidine twice daily for 3 months, insulin sensitivity (HOMA) and HDL cholesterol levels increased, with a small reduction in beta oxidation of FFA beta oxidation and increase in EF, which decreased in the placebo group.",
  "reading_complete" : "2020-07-28T17:24:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:22:27Z",
  "trigger" : "increased",
  "evidence" : [ "cholesterol levels increased, with a small reduction in beta-oxidation of FFA beta-oxidation and increase in EF" ],
  "pmc_id" : "6898975",
  "score" : 0
}